Skyhawk, Therapeutics

Skyhawk Therapeutics Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntington's Disease

Veröffentlicht: 17.03.2026 um 18:22 Uhr, prnewswire.co.uk

Skyhawk Therapeutics Massachusetts

View original content:https://www.prnewswire.co.uk/news-releases/skyhawk-therapeutics-appoints-aaron-deves-as-chief-commercial-officer-to-lead-commercialization-of-sky-0515-for-huntingtons-disease-302709626.html

en | boerse | 68721515 |